Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD19 and CD22 chimeric antigen receptors and uses thereof

CD19 and CD22 chimeric antigen receptors and uses thereof

US Patent 11975026 · Granted May 7, 2024

Estimated economic value: $41,750,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors and uses thereof2025
Chimeric antigen receptors and uses thereof2025
CD19 and CD22 chimeric antigen receptors and uses thereof2025
CD19 and CD22 chimeric antigen receptors and uses thereof2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Human mesothelin chimeric antigen receptors and uses thereof2024
Compositions and methods for selective protein degradation2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Method of treating cancer by administering immune effector cells expressing a ch2024